Electronic products manufacturer AMETEK (NYSE: AME) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 13.4% year on year to $2.00 billion. The company expects next quarter’s revenue to be around $1.91 billion, close to analysts’ estimates. Its non-GAAP profit of $2.01 per share was 3.4% above analysts’ consensus estimates.

Is now the time to buy AME? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

AMETEK’s fourth quarter demonstrated continued momentum, as management cited strong sales and order growth, with recent acquisitions contributing notably to revenue expansion. CEO Dave Zapico highlighted robust performance across both the Electronic Instruments and Electromechanical segments, and pointed to a record backlog as evidence of sustained demand. Management credited disciplined pricing actions and a refreshed product portfolio for supporting profitability, even as operating margins came under pressure due to the integration of lower-margin acquired businesses.

Looking forward, AMETEK’s guidance for the coming year reflects expectations of steady growth in its core markets, underpinned by ongoing investment in research, development, and targeted acquisitions. Zapico emphasized that “differentiated technologies and deep industry expertise” are expected to support growth in attractive niche segments, while CFO Dalip Puri detailed plans for incremental investment in digital and engineering initiatives. Management noted that margin expansion will be gradual, as newly acquired businesses are integrated and operational improvements are realized across the portfolio.

Key Insights from Management’s Remarks

Management attributed quarterly performance to the successful integration of acquisitions, a diversified industry portfolio, and strength in end markets such as medical technology and aerospace.

• Acquisitions boost revenue: The completed acquisitions of Ferro Technologies and Kern Micro Technique added significant sales, with integration efforts underway to improve margins and align operations with AMETEK’s model.
• Medical technology expansion: The acquisition of LKC Technologies broadened AMETEK’s med tech exposure, particularly in diagnostics for ophthalmic conditions, and introduced recurring revenue streams from consumables.
• Strong aerospace and defense demand: Management cited high single-digit organic growth in aerospace and defense, fueled by rising content on both commercial and defense platforms, and recent wins in European defense programs.
• Geographic strength, especially in Asia: Sales in China grew at a low double-digit rate, driven by demand in process automation, power, and clean energy infrastructure, while U.S. and European markets also contributed to overall growth.
• Pricing discipline and portfolio refresh: Positive price-cost spread was maintained as management offset inflation and tariffs through pricing, supported by a 30% vitality index reflecting new product introductions over the last three years.

Drivers of Future Performance

Management expects acquisitions, ongoing innovation, and a strong backlog to drive revenue and margin trends in the coming year, though integration costs and macroeconomic uncertainty remain key considerations.

• Acquisition integration and synergy capture: The outlook assumes continued improvement in margins as recently acquired businesses, such as FARO and Paragon, are integrated and operational synergies are realized, though lower initial margins from these deals will weigh on early results.
• End-market and geographic diversification: Growth is expected across medical technology, aerospace, defense, and power markets, with Asia and China providing outsized contributions. Management anticipates mid-single digit organic growth in core segments, supported by robust demand pipelines.
• Disciplined pricing and cost management: Management believes pricing actions and cost controls will offset inflation and tariff headwinds, with incremental investments in R&D and digital initiatives expected to support long-term competitiveness despite near-term operating margin pressure.

Catalysts in Upcoming Quarters

In the coming quarters, our team will closely monitor (1) the pace and effectiveness of integrating newly acquired businesses and their margin improvement, (2) the trajectory of organic growth in key end markets such as aerospace, medical technology, and power, and (3) the sustainability of price-cost management as inflation and tariff pressures persist. Investments in product innovation and digital capabilities will also be critical indicators of future performance.

AMETEK currently trades at $227.09, in line with $227.72 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

Stocks That Trumped Tariffs

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.